The dipeptidyl peptidase IV inhibitor vildagliptin suppresses endogenous glucose production and enhances islet function after single-dose administration in type 2 diabetic patients.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples